Short Term Effect of Pre-Operative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membranes of Proliferative Diabetic Retinopathy
Investigative Ophthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.4.37 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2024. Verfasst von Kaveh Fadakar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor A, Bevacizumab. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Purpose
Adjuvant, pre-operative intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections have been used to reduce peri-operative bleeding in eyes undergoing pars-plana vitrectomy for complications of proliferative diabetic retinopathy (PDR). To address the concern over their potential off-target effects of progressive fibrous contraction, we sought to dissect the transcriptional changes in the surgically extracted fibrovascular membranes (FVMs).
Methods
We analyzed surgically extracted FVMs from 10 eyes: 4 eyes pretreated with intravitreal bevacizumab (IVB) and 6 untreated eyes. FVMs were digested into single cells, mRNA was extracted from endothelial cell-enriched (microbead selection with CD31) and non-endothelial cell compartments, followed by RT-qPCR quantification. We then compared the relative expression of genes involved in angiogenesis, endothelial cell integrity, and myofibroblastic processes between treated and untreated FVMs.
Results
Endothelial cells from IVB pretreated FVMs showed significant reduction of VEGFA, VEGF receptors (FLT1 and KDR), and angiopoietin 2 expression as well as increased vascular endothelial cadherin and endothelin, suggesting reduced angiogenesis and enhanced vascular integrity. The non-endothelial cell fraction showed decreased expression of VEGFA and fibronectin, without significant difference in the expression of other profibrotic factors.
Conclusions
Our findings confirm that adjuvant pre-operative IVB decreased fibronectin and increase endothelin-1 expression without affecting other profibrotic gene expression, uncovering an important interaction between IVB and endothelin-1 that deserves further study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
- Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Förderung
- NEI NIH HHS
Zitieren
APA
Fadakar, K., Rahmani, S., Tedeschi, T., Lavine, J. A., & Fawzi, A. A. (2024). Short Term Effect of Pre-Operative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membranes of Proliferative Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.65.4.37
Vancouver
Fadakar K, Rahmani S, Tedeschi T, Lavine JA, Fawzi AA. Short Term Effect of Pre-Operative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membranes of Proliferative Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 2024. doi:10.1167/iovs.65.4.37
BibTeX
@article{Fadakar2024,
author = {Fadakar, Kaveh and Rahmani, Safa and Tedeschi, Thomas and Lavine, Jeremy A and Fawzi, Amani A},
title = {Short Term Effect of Pre-Operative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membranes of Proliferative Diabetic Retinopathy},
journal = {Investigative Ophthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.4.37}
}
EUVIMED